Answer
The controversial price inflation was orchestrated by Martin Shkreli, former CEO of Turing Pharmaceuticals. Shkreli gained notoriety for raising the cost of Daraprim, a drug used to treat a parasitic infection, by over 5,000% in 2015. This act sparked public outrage and scrutiny of the pharmaceutical industry's pricing practices.